Risk of sudden unexpected death in epilepsy (SUDEP) with lamotrigine and other sodium channel‐modulating antiseizure medications

Risk of sudden unexpected death in epilepsy (SUDEP) with lamotrigine and other sodium channel‐modulating antiseizure medications

Abstract Objective In vitro data prompted U.S Food and Drug Administration warnings that lamotrigine, a common sodium channel modulating anti‐seizure medication (NaM‐ASM), could increase the risk of sudden death in patients with structural or ischaemic cardiac disease, however, its implications for...

Full description

Bibliographic Details
Main Authors: Russell Nightscales, Sarah Barnard, Juliana Laze, Zhibin Chen, Gerard Tao, Clarissa Auvrez, Shobi Sivathamboo, Mark J. Cook, Patrick Kwan, Daniel Friedman, Samuel F. Berkovic, Wendyl D'Souza, Piero Perucca, Orrin Devinsky, Terence J. O'Brien
Format: Article
Language:English
Published: Wiley 2023-06-01
Series:Epilepsia Open
Online Access:https://doi.org/10.1002/epi4.12693

Internet

https://doi.org/10.1002/epi4.12693

Similar Items